Ligand Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.02.14	CADX Snapped Up, HNSN Gets FDA Nod, NNVC Rejects Report's Claims, NVLT Renamed (RTTNews)
03.02.14	GlaxoSmithKline Gets FDA Breakthrough Therapy Designation For Promacta/Revolade (RTTNews)
04.12.13	Ligand Pharma Lifts Q4, 2013 Outlook; Backs 2014 Guidance - Quick Facts (RTTNews)
02.10.13	Regulatory Approval, New Appointments, Stock Price Movements, and Other Announcements - Research Report on Pfizer, Warner Chilcott, Rockwell Medical, InterMune, and Ligand (PR Newswire)
29.07.13	New License Agreements and Financial Results Release - Research Report on Elan, Waters, InterMune, Spectranetics, and Ligand (PR Newswire)
22.06.11	Northern Virginia Regional Health Information Organization Inc. Launches Innovative Medication History Service (Businesswire)
22.06.11	Northern Virginia Regional Health Information Organization Inc. Launches Innovative Medication History Service (Businesswire)
06.06.11	Dell Kicks Off Inaugural Dell Storage Forum, Welcoming Hundreds of Customers and Partners to Learn about Company’s World-Class Storage Technology (Businesswire)
25.10.10	Deutsche Bank Hosts 16th Annual Women on Wall Street® Conference (Businesswire)
08.10.10	Ligand Appoints Sunil Patel to Board of Directors (Businesswire)
21.06.10	Ligand to Webcast Analyst Day on June 24 (Businesswire)
21.06.10	Ligand to Webcast Analyst Day on June 24 (Businesswire)
21.05.10	A New Audio Interview with Stephen Johnston, President and CEO of AISystems, Inc. is Now at SmallCapVoice.com (Businesswire)
05.05.10	Targacept Reports First Quarter 2010 Financial Results (Businesswire)
26.04.10	Autodesk Launches Easy-to-Use, Low-Cost Drawing Software (Businesswire)
20.04.10	Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2010 Earnings Per Share of $0.07, Including a One-Time Charge Totaling $0.76 Per Share (Businesswire)
09.02.10	Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Results (Businesswire)
18.12.09	Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura (Businesswire)
20.11.09	Ligand Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual Meeting (Businesswire)
27.10.09	Ligand to Acquire Metabasis for Cash and Contingent Value Rights (Businesswire)
24.08.09	Ligand to Acquire Neurogen for Stock and Contingent Value Rights (Businesswire)
06.08.09	Metabasis Therapeutics Announces Second Quarter 2009 Financial Results (Businesswire)
06.05.09	Ligand Pharmaceuticals Announces First Quarter Results (Businesswire)
02.03.09	Metabasis Therapeutics Appoints Tran B. Nguyen as Vice President and Chief Financial Officer (Businesswire)
09.02.09	Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer’s Disease (Businesswire)
18.12.08	Ligand Enters into Exclusive License Agreement with GlaxoSmithKline to License Rights to LGD-4665 and other Ligand Thrombopoietin (TPO) Molecules (Businesswire)
08.12.08	Ligand Presents Positive LGD-4665 Clinical Trial Results at the American Society of Hematology Annual Meeting (Businesswire)
24.09.08	Ligand to Acquire Pharmacopeia for Stock and Contingent Value Rights (Businesswire)
05.09.08	Ligand Pharmaceuticals and the SALK Institute Enter Settlement Agreement and Mutual Release of All Claims (Businesswire)
05.11.07	Metabasis Presents Preclinical Results at AASLD Showing MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, Reduces Liver Fat (Businesswire)
08.08.07	Ligand Pharmaceuticals Announces Second Quarter Results (Businesswire)
26.02.07	King Pharmaceuticals Completes Strategic Acquisition of AVINZA(R) (Businesswire)
16.05.05	Investigators Present Detailed Targretin Lung Cancer Data from SPIRIT (Businesswire)
28.03.05	Targretin Fails to Meet Primary or Secondary Endpoints in Pivotal Tria (Businesswire)
14.03.05	Ligand and SRI/Burnham Agree to Settle Patent Interference on Targreti (Businesswire)
03.02.05	Pfizer Submits SNDA to Expand Potential Market for Lasofoxifene; Trigg (Businesswire)
02.02.05	Ligand Announces Acceleration of Employee Stock Option Vesting (Businesswire)
27.01.05	Ligand Provides Update and Answers to Frequently Asked Questions on th (Businesswire)
11.01.05	CORRECTING and REPLACING Ligand Presentation at JP Morgan Healthcare C (Businesswire)
03.01.05	Ligand Pharmaceuticals Receives Leadership Award from Frost & Sullivan (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09.12.24		Minuszeichen in New York: So bewegt sich der NASDAQ Composite am Montagnachmittag
08.11.24		NASDAQ-Handel: NASDAQ Composite schlussendlich mit Kursplus
08.11.24		Gute Stimmung in New York: NASDAQ Composite nachmittags freundlich
08.11.24		Börse New York in Grün: NASDAQ Composite bewegt sich zum Start im Plus
09.07.24		Börse New York: NASDAQ Composite beendet die Sitzung im Plus
09.07.24		Gute Stimmung in New York: NASDAQ Composite nachmittags mit Kursplus
09.07.24		NASDAQ Composite aktuell: NASDAQ Composite klettert mittags
13.06.24		Aufschläge in New York: NASDAQ Composite klettert zum Handelsende

09.12.24

Minuszeichen in New York: So bewegt sich der NASDAQ Composite am Montagnachmittag

08.11.24

NASDAQ-Handel: NASDAQ Composite schlussendlich mit Kursplus

08.11.24

Gute Stimmung in New York: NASDAQ Composite nachmittags freundlich

08.11.24

Börse New York in Grün: NASDAQ Composite bewegt sich zum Start im Plus

09.07.24

Börse New York: NASDAQ Composite beendet die Sitzung im Plus

09.07.24

Gute Stimmung in New York: NASDAQ Composite nachmittags mit Kursplus

09.07.24

NASDAQ Composite aktuell: NASDAQ Composite klettert mittags

13.06.24

Aufschläge in New York: NASDAQ Composite klettert zum Handelsende

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.59	1.92 %	K V
Kuehne+Nagel Int	207.80	1.37 %	K V
Part Grp Hldg	1’231.50	1.11 %	K V
Novartis	88.55	0.99 %	K V
CieFinRichemont	137.25	0.84 %	K V
Sonova Hldg	296.40	0.27 %	K V
Swiss Life Hldg	698.00	0.20 %	K V
Sika	215.40	-0.05 %	K V
Zurich Insur Gr	538.40	-0.11 %	K V
Holcim	87.06	-0.37 %	K V

Nachrichten zu Ligand Pharmaceuticals Inc

Aktien Top/Flop

Ligand Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten